Cerus Corporation (CERS): Price and Financial Metrics
CERS Price/Volume Stats
| Current price | $1.85 | 52-week high | $3.08 |
| Prev. close | $1.79 | 52-week low | $1.21 |
| Day low | $1.76 | Volume | 1,083,600 |
| Day high | $1.88 | Avg. volume | 1,471,959 |
| 50-day MA | $1.88 | Dividend yield | N/A |
| 200-day MA | $1.86 | Market Cap | 342.05M |
CERS Stock Price Chart Interactive Chart >
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
Latest CERS News From Around the Web
Below are the latest news stories about CERUS CORP that investors may wish to consider to help them evaluate CERS as an investment opportunity.
Positive week for Cerus Corporation (NASDAQ:CERS) institutional investors who lost 54% over the past yearKey Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading... |
Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call TranscriptCerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript November 2, 2023 Cerus Corporation beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.05. Operator: Good day and thank you for standing by. Welcome to Cerus Corporation Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ […] |
Cerus Corporation to Participate in Upcoming Investor ConferencesCONCORD, Calif., November 03, 2023--Cerus Corporation (NASDAQ:CERS) announced today that the Company will participate in two upcoming investor conferences: |
Cerus Corp (CERS) Q3 2023 Earnings: Product Revenue Stable, Operating Expenses Decrease by 4%Company reaffirms commitment to achieve non-GAAP adjusted EBITDA breakeven in Q4 2023 |
Cerus (CERS) Reports Q3 Loss, Lags Revenue EstimatesCerus (CERS) delivered earnings and revenue surprises of 40% and 2.76%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? |
CERS Price Returns
| 1-mo | -2.63% |
| 3-mo | -19.57% |
| 6-mo | 15.63% |
| 1-year | -14.35% |
| 3-year | -69.85% |
| 5-year | -66.61% |
| YTD | -14.35% |
| 2023 | -40.82% |
| 2022 | -46.40% |
| 2021 | -1.59% |
| 2020 | 63.98% |
| 2019 | -16.77% |
Continue Researching CERS
Want to see what other sources are saying about Cerus Corp's financials and stock price? Try the links below:Cerus Corp (CERS) Stock Price | Nasdaq
Cerus Corp (CERS) Stock Quote, History and News - Yahoo Finance
Cerus Corp (CERS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...